All Type of News
More tax exemptions set for R&D spending
Korea seeks to expand tax exemptions for corporate investment in research and development (R&D) as part of efforts to stimulate state-run and private companies’ R&D spending in the era of free trade agreements (FTAs)....
Voluntary agreement against illegal rebate unveiled
The Korea Pharmaceutical Manufacturers' Association and the Korean Research-Based Pharmaceutical Industry Association have come up with detailed standards defining rebates in their self-imposed agreement for transpare...
Kozin opens medical tourism website
Kozin EBI has unveiled its new look medical tourism website “Doctor Seoul” (www.doctorseoul.com) for foreigners, the company said.
The new website is aimed at providing foreign patients visiting the Doctor Seoul we...
Green Cross reports positive results from phase 3 trials of Peramivir for influenza
Green Cross Corporation announced on July 28 the positive results from two Phase 3 studies of intravenous peramivir in patients with seasonal influenza.
The studies were sponsored by the US based BioCryst's partner...
80% are displeased with medication costs
About 80 percent of subscribers show dissatisfaction about the current drug cost system, a poll said recently.
According to the survey conducted by the National Health Insurance Corporation, 79.3 percent called for...
Pharmaceutical firms urged to improve salespersons morale
Korean drug makers should need to boost the morale of their sales forces amid more cut-throat competition in domestic pharmaceutical market,
Pharmaceutical companies have been blamed for what is called “rebate” pra...
Green Cross obtains exclusive distribution rights for somatostatin injection
Green Cross Corporation said on July 24 it has signed an agreement with he Korean subsidiary of Merck KGaA Germany for the exclusive distribution rights in Korea for Stilamin injection (somatostatin acetate).
Somat...
Chong Kun Dang Bio gets EDQM certification
Chong Kun Dang Bio, an affiliate company of Chong Kun Dang Pharmaceutical Co., said on July 22 it has received a CEP (Certificate of European Pharmacopoeia) from the European Directorate for the Quality of Medicines &...
Wonik to team up with Solta Medical
Wonik Corp., a local medical device company, plans to strengthen its ties with with the US based Solta Medical Inc. as an official business partner in Korea.
Solta Medical is a global leader in the medical aestheti...
Government backs development of biopharmaceuticals
The Ministry of Health, Welfare and Family Affairs said on July 23 that it plans to earmark 30 billion won for the development of new biopharmaceutical products.
Through the increased backing, the health ministry p...
